Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese health study

American Journal of Epidemiology

Volumn 167, Issue 5, 2008, Pages 553-560

  Tan, Louis C ^a   Koh, Woon Puay ^b   Yuan, Jian Min ^c   Wang, Renwei ^c   Au, Wing Lok ^a   Tan, June H ^d   Tan, Eng King ^a   Yu, Mimi C ^c  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Asian continental ancestry group; Coffee; Food and beverages; Parkinson disease; Singapore; Smoking; Tea

Indexed keywords

CAFFEINE;

ANCESTRY; COHORT ANALYSIS; COMPARATIVE STUDY; DATABASE; ETHNIC GROUP; FOOD; HEALTH RISK; HEALTH SURVEY; NERVOUS SYSTEM DISORDER; QUESTIONNAIRE SURVEY; RISK FACTOR; SMOKING; TEA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET; DISEASE REGISTRY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARKINSON DISEASE; RISK; SINGAPORE; SMOKING; STRUCTURED QUESTIONNAIRE; TEA;

AGED; CAFFEINE; CHINA; DRINKING BEHAVIOR; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; LIFE STYLE; MALE; NUTRITION ASSESSMENT; PARKINSON DISEASE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK; RISK ASSESSMENT; RISK FACTORS; SINGAPORE; TEA;

ASIA; CHINA; EURASIA; FAR EAST; SINGAPORE [SOUTHEAST ASIA]; SOUTHEAST ASIA;

CAMELLIA SINENSIS; NICOTIANA TABACUM;

EID: 40049089744     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm338     Document Type: Article

References (34)

1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-35.
2. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-6.
3. Hernan MA, Takkouche B, Caamano-Isorna F, et al. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-84.
4. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 2004;27:561-8.
5. Chen JF, Xu K, Petzer JP, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001;21:RC143.
6. Tan EK, Tan C, Fook-Chong SM, et al. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci 2003;216:163-7.
7. Chan DK,Woo J, Ho SC, et al. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 1998;65:781-4.
8. Tan LC, Venketasubramanian N, Hong CY, et al. Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians. Neurology 2004;62:1999-2004.
9. Hankin JH, Stram DO, Arakawa K, et al. Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 2001;39:187-95.
10. Seow A, Shi CY, Franke AA, et al. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 1998;7:135-40.
11. Seow A, Shi CY, Chung FL, et al. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev 1998;7:775-81.
12. Heng DM, Lee J, Chew SK, et al. Incidence of ischaemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore Cardiovascular Cohort Study. Ann Acad Med Singapore 2000;29:231-6.
13. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
14. Tan LC, Venketasubramanian N, Jamora RD, et al. Incidence of Parkinson's disease in Singapore. Parkinsonism Relat Disord 2007;13:40-3.
15. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704.
16. Checkoway H, Powers K, Smith-Weller T, et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-8.
17. Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
18. Chaturvedi RK, Shukla S, Seth K, et al. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis 2006;22:421-34.
19. Ragonese P, D'Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 2004;62:2010-14.
20. Currie LJ, Harrison MB, Trugman JM, et al. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol 2004;61:886-8.
21. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.
22. Green PS, Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 2000;18:347-58.
23. Wu AH, Arakawa K, Stanczyk FZ, et al. Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis 2005;26:976-80.
24. Hernan MA, Zhang SM, Rueda-deCastro AM, et al. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 2001;50:780-6.
25. Grandinetti A, Morens DM, Reed D, et al. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-38.
26. Ross GW, Petrovitch H. Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging 2001;18:797-806.
27. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000;283:2674-9.
28. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992;17:139-70.
29. Richardson PJ, Kase H, Jenner PG. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 1997;18:338-44.
30. Kanda T, Tashiro T, Kuwana Y, et al. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. Neuroreport 1998;9:2857-60.
31. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 2006;7:207-19.
32. Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 2005;4:362-5.
33. Zhang SM, Hernan MA, Chen H, et al. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 2002;59:1161-9.
34. Chen H, Zhang SM, Schwarzschild MA, et al. Folate intake and risk of Parkinson's disease. Am J Epidemiol 2004;160:368-75.